DAFTAR PUSTAKA
Albert, H., Bwanga, F., Mukkada, S. 2010. Rapid Screening of TB MDR Using Molecular Line Probe Assay in Feasible in Uganda. BMC Infectious Diseases. 10(41). 1471- 9
Amin, Z., Bahar, A. 2014. Tuberkulosis Paru. Dalam: Buku Ajar Ilmu Penyakit Dalam. Jilid I. Edisi VI. Jakarta: Pusat Penerbitan Departemen Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Indonesia. Hal: 864-8.
Bacahoglu, F., Basoghu, OK., Cog, G., Saymer, A. 2011. Pulmonary tuberculosis in patients with Diabetes Mellitus. Respirology. 68:595-600.
Blakemore, R., Story, E., Helb, D., Kop, J. 2010. Evaluation of Analytical Performance of The Xpert MTB/RIF Assay. 48(7): 2495-501.
Burhan, E. 2010. Peran ISTC dalam Pencegahan MDR. Jurnal Tuberkulosis Indonesia. 7:12-5.
Boehme, CC. 2009. Study Protocol-Xpert MTB/RIF Demonstration-feasibility, Impact, and Cost-efficiency of Decentralizing Molecular Testing for Detection of Tuberculosis and Rifampisin Resistance Using Xpert MTB/RIF. 1495-505
Boehme, CC., Nabeta P., Hilleman D., Nicol PM., Shenai S., Krapp F., at al. 2010. Rapid Molecular Detection of Tuberculosis and Rifampisin Resistance. The New England Journal of Medicine. 363(11):1005-15.
Boulware, LR. 2013. Utility of The Xpert MTB/RIF Assay for Diagnosis of Tuberculosis Meningitis. PLoS Med. 10(10). 11-8
Calligaro, G., Moodley, L., Symons, G., Dheda, K. 2014. The Medical and Surgical Treatment of Drug Resistant Tuberculosis. Journal Thoracal Diseases. 6(3). 186-95.
Chiang CY, Centis R, Migliori GB. 2010. Drug Resistant Tuberculosis: past, present, future. Respirology. 15(3):413-32.
Departemen Kesehatan Republik Indonesia, 2009. Pedoman Nasional Penanggulangan Tuberkulosis. Jakarta: Depkes RI. 80
Departemen Kesehatan Republik Indonesia. 2013. Pedoman Manajemen Terpadu Pengendalian Tuberkulosis Resisten Obat. Jakarta : Depkes RI. 15-26
78
Dwiastuti, I. 2012. Analisis Prilaku Pada Kejadian TB Paru Resisten di Kota Makassar [Skripsi]. Fakultas Kesehatan Masyarakat Universitas Hasanuddin Makssar. 42-3
Evans, CA. 2011. GeneXpert- A Game Changer For Tuberculosis Control?. PLoS Med. 8(7). 56-69
Falzon, D., Mirzayev, F., Wares, F., Baena G., Zignol M., Linh N., et al. 2014. Multidrug- resistant tuberculosis around the world: What Progress Has Been Made ?. European Respiratory journal. 150-60
Hakeem, A., Hussain, MS., Imran, MI. 2013. GeneXpert MTB/RIF- A Novel Diagnostic Tool for Tuberculosis in Pulmonary Samples. 8: 1-3.
Hillemann, D., Weizenegger, M., Kubicat., Richter, E., Niemann, S. 2005. Use of the Genotype TB MDR Assay for Rapid Detection of Rifampisin and Isoniazid Resistance in Mycobacterium tuberculosis Complex Isolates. Journal of Clinical Microbiology. 43(8): 3699-703.
Hirpa, S., Medhin, G., Girma, B., Melese, M., mekonen, A., Suarez, P., et al. 2013. Determinants of multidrug-resistant tuberculosis in patients who underwent first-line treatment in Addis Ababa: a case control study. BMC Public Health. 13: 782.
Kasper, DL., Braunwald, S., Hauser, D., Longo, L., Jameson., and Fauci. 2008. “Tuberculosis,” in Harrison's Principle of Internal Medicine, pp., McGraw-Hill, New York, NY, USA, 17th edition. 953–66
Kementerian Kesehatan Republik Indonesia. 2011. Rencana Aksi Nasional Programmatic Management of Drug Resistance Tuberculosis. Direktorat Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan. 40-5
Kementerian Kesehatan Republik Indonesia. 2013. Pedoman Nasional Pelayanan Kedokteran Tatalaksana Tuberkulosis. 30-6
Kementerian Kesehatan Republik Indonesia. 2014. Pedoman Nasional Pengendalian Tuberkulosis. Direktorat Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan. 51-60
Lawn SD, Nicol MP. 2011. Xpert MTB/RIF Assay: Development, Evaluation, and Implementation of a New Rapid Molecular Diagnostic for Tuberculosis and Rifampisin Resistance. Future Microbiology. 6(9):1067-82.
Lawn, SD., Wood R. 2011. Tuberculosis in Antiretroviral Treatment Services in Resources Unlimited Setting ; Adressing the Challenges of Screening and Diagnosis. Journal Infectious Disease. 204: 1159-67.
Li J, Xin J, Zhang L, Jiang L, Cao H, Li L. 2012. Rapid Detection of rpoB Mutations in Rifampisin Resistant Mycobacterium tuberculosis from Sputum Samples by Denaturing Gradient Gel Electrophoresis. Int J Med Sci. 9(2):148-56.
Makadia JS, Jain A, Patra SK, Sherwai BL, Khanna A. 2012. Emerging trend of mutation profile of rpob gene in MDR tuberculosis, North India. Ind J Clin Biochem. 27(4): 370-4.
Marlowe, EM., Novan, SM., Cumpio, J. 2011. Evalution of The Cepheid Xpert MTB/RIF Assay for Direct Detection of Mycobacterium Tuberculosis Complexin Respiratory Speciments, Journal Clinical Microbiology. 49(4). 1621.
Munir, S.M., Nawas, A., dan Soetoyo, D. 2010. Pengamatan Pasien Tuberkulosis Paru dengan Multidrug Resistant (TB-MDR) di Poliklinik Paru RSUP Persahabatan. Jurnal Respirologi Indonesia. 30(2): 92-9.
Nawas, A. 2010. Penatalaksanaan TB MDR dan Strategi DOTS Plus. Jurnal Tuberkulosis Indonesia. 7: 1-6.
Nikmawati, Windarwati, dan Hardjoeno. 2005. Resistensi Mycobacterium tuberculosis terhadap Obat Anti Tuberkulosis. Indonesian Journal of clinical Pathology and Medical Laboratory. 12(2): 58-61.
Noviana H, Nurachman Z, Ramdani M, Noe A. 2007. Multiplex PCR for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis Isolated from Bandung, Indonesia. Microbiology Indonesia. 1(3):114-8. Nofizar, D., Nawas, A., dan Burhan, E. 2010. Identification of Risk Factor in
Multidrug Resistant Tuberculosis. Majalah Kedokteran Indonesia. 60(12): 538-54.
Pant, R., Pandey, KR., Joshi, M., Sharma, M., Pandey, T., Pandey, S. 2009. Risk Factor Assesment of Multidrug Resistant Tuberculosis. 7(15): 89-92.
Perhimpunan Dokter Paru Indonesia. 2011. Pedoman Diagnosis dan Penatalaksanaan Tuberkulosis di Indonesia. 43-5
Price, S.A., Wilson, L.M. 2012. Patofisiologi: Konsep Klinis Proses-Proses Penyakit. Edisi 6. Jakarta: EGC. 852
80
Putri, AV., Yozi, I., Fauzia, D. 2015. Profil Pasien Tuberkulosis Multidrug Resistance (TB MDR) di Poliklinik TB MDR RSUD Arifin Achmad Provinsi Riau Periode April 2013-Juni 2014. JOM. 1(2). 1-8
Raizada, N., Sachdeva, KS., Chauhar, DS., et al. 2014. A Multi-site Validation in India of the Line Probe Assay for the Rapid Diagnosis of Multi Drug-resistant Tuberculosis Directly From Sputum Speciments. PLoS One. 9(2). 1-8
Ramirez, MV., Cowart, KC. Campbell, PJ., Morlock, GP., Sikes, D., Winchell, JM., et al. 2010. Rapid Detection of Multidrug Resistant Mycobacterium tuberculosis by Use Realtime PCR and High Resolution Melt analysis. J Clin Microbiology. 48(11): 4003-9.
Rufai, BS., Kumar, P., Singh, A., Prajapati, S., Balboni, V., Singh, S. 2014. Comparison of Xpert MTB/RIF with Line Probe Assay for Detection of Rifampisin Resistance-Monoresistant Mycobacterium tuberculosis. JCM. 52(6): 1846-52
Sarwani, D., Nurlaela, S., Zahratul, I. 2012. Analisis Faktor Risiko Multidrug Resistant Tuberculosis (TB MDR) (Studi Kasus di BP4 Purwokerto). Jurnal Kesehatan Masyarakat. 8(1): 62-8.
Sihombing, H., Sembiring, H., Amir, Z., dan Sinaga, B. 2011. Pola Resistensi Primer pada Penderita TB Paru Kategori I di RSUP H. Adam Malik Medan. Jurnal Respirasi Indonesia. 32(2):138-45.
Sinaga, M.Y. 2013. Karakteristik penderita Multidrug Resistant Tuberculosis yang mengikuti Programmatic Management of Drug Resistant Tuberculosis di Rumah Sakit Umum Pusat H.Adam Malik Medan. Jurnal Respirasi Indonesia. 33(4): 221-8.
Soedarsono. 2010. Multidrugs-Resistant (MDR) TB. Dalam: Buku Ajar Ilmu Penyakit Paru 2010. Surabaya: Departemen Ilmu Penyakit Paru Fakultas Kedokteran Universitas Airlangga- RSUD Dr. Soetomo. Hal: 27-36.
Soepandi P.Z. 2010. Diagnosis dan Penatalaksanaan TB MDR. Jakarta: Depatemen Pulmonologi dan Ilmu Kedokteran Respirasi FKUI- RSUP Persahabatan. 497-501
Steingart, KR, Sohn, N., Shiller, L. 2013. Xpert MTB/RIF Assay for Pulmonary Tuberculosis and Rifampisin Resitance in Adults (Review). 1: 1-35.
Syahrini, H. 2008. Tuberkulosis Paru Resistensi Ganda. USU e-Repository. Medan: Fakultas Kedokteran USU. 10-2
Tirtana, BT. 2011. Faktor-faktor yang Mempengaruhi Keberhasilan Pengobatan pada Pasien Tuberkulosis Paru dengan Resistensi Obat Tuberkulosis di Wilayah Jawa Tengah [skripsi]. Semarang : Fakultas Kedokteran Universitas Diponegoro. 1-19
Trebucq, A, Enarson, DA., Chiang, CY. 2011. Xpert MTB/RIF for National Tuberculosis Programmes in Low Incomes Countries: When, Where, and How?. Int J Tuberculosis Lung Diseases.15(12): 1567-71.
Van Rie, A., Page-ship, L., Scott, L., Sanne, I., Steven, W. 2010. Xpert MTB/RIF for Point Care Diagnosis of TB in High HIV Burden, Resources Limited Countries: Hype or Hope?. Expert Mol diagn. 10(7): 937-46.
TB MDR. Manajemen Terpadu Pengendalian TB Resisten Obat (MTPTRO) http://www.tbindonesia.or.id/tb-mdr/diakses tanggal 25 Maret 2015
TB-MDR. http://indonesia.etbmanager.org/blog/?page_id=221 diakses tanggal 30 Mei 2015
World Health Organization . Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis: Emergency Update 2013. Geneva: WHO Press 2013. World Health Organization. Drug Resistant TB: Surveillance and Response. Geneva:
WHO Press 2014.
World Health Organization. Global Tuberculosis Report 2015. Geneva: WHO Press 2015.
World Health Organization. Molecular Line Probe Assay for Rapid Screening of Patients at Risk of Multidrug Resistant Tuberculosis (TB MDR). Geneva: WHO; 2008.
World Health Organization. Rapid Implementation of the Xpert MTB/RIF Diagnostic Test. Geneva: WHO; 2011.
World Health Organization. Tuberculosis Diagnostics Xpert MTB/RIF Test. Geneva: WHO 2013
World Health Organization. The Global Plan to Stop TB 2011-2015. Geneva: WHO 2011.
Yadav, RN., Singh, BK., Sharma, SK. Comparative Evaluation of Genotype MTBDRplus Line Probe Assay With Solid Culture Method In Early Diagnosis of Multidrug Resistant Tuberculosisat a Tertiary Care Center in India. PLoS One. 1-6
82
Yuan, X., Zhang, T., Kawakami, K., et al. 2013. Genotyping and Clinical Characteristics of Multidrug and Extensively Drug Resistant Tuberculosis in Tertiary Care Tuberculosis Hospital in China. BMC Infectious Diseases. 13(385). 525-30
